Royal DSM N.V., headquartered in the Netherlands, has received a grant from the US Department of Energy for a technical consortium on an innovative biotechnological approach of bioproducts and biofuels.
The grant will fund an extensive enzyme development program which will focus
on finding applications in cellulose-based biorefineries for the production of
bio-based products, including biofuels.
The research will be carried out
by a technical consortium in which DSM will be the lead partner. The other
participants in this proposed project include Abengoa Bioenergy New
Technologies, Los Alamos Laboratory and Sandia National Laboratory. An important
part of the development work will be executed in the US and the program will run
for four years.
The grant fits in with the extensive White Biotech
program that DSM is running as one of its Emerging Business Areas with the aim
of becoming a company fully focused on Life Sciences and Materials Sciences in
line with its strategy Vision 2010. It will enlarge DSM’s capabilities as
a leader in biotechnology.
Commercially feasible
Global
developments across all technology platforms in bio-conversion of cellulosic
feedstocks are still at an early stage. In order to create and utilize
commercially feasible solutions, the integration of technologies across the
complete value chain and the manufacturing and entrepreneurial skills of
companies such as of DSM and Abengoa are essential. This collaboration allows
DSM to more rapidly develop and test technology at semi-commercial and full
commercial scale in existing and pilot plants.
DSM’s main field of
interest in this program is to develop the technical skills for cellulosic
biomass hydrolysis. After completion of this program DSM will decide upon
further research and partners to collaborate within this field.
Related folder:
Dossier AllAbout Bio Energy
Related
website:
DSM